Wang Gui-qing, Huang Jiu-yi, Shen Feng-ying, Wang Yan, Cao Yi-feng, Guo Ji-ping, Yu Xue-hai, Mou Wei-yan, Wang Su-chun, Yang Yong-ju, Lin Jian-ming, Fu Guo-xin
Shanghai Institute of Cerebral Vascular Disease Intervention and Cure, Shanghai 201318, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2005 May;26(5):335-8.
To evaluate the effectiveness of stroke prevention among high risk population, using Nao'an Capsules.
Participants were selected from 696,558 residents in Nanhui, using county of Shanghai city. Individuals aged 35 years old and over with at least one risk factor exposure to stroke, received cerebral vascular hemodynamic examination. 18,271 cases meeting the criteria of cerebral vascular hemodynamic indexes accumulative score below 70 points were defined as individuals with high-risk and targets to receive intervention. According to the willingness of the participants, 10,313 cases received Nao'an Capsules for intensive intervention based on general intervention measures compared to 7958 cases only receiving general intervention. After the implementation of intervention, incidence and mortality rates of stroke and the effectiveness of three-year intervention were studied.
Incidence of stroke in Nao'an Capsules group was significantly lower than that of the general intervention (P < 0.01) with 53.8% in males and 58.4% in females. The relative risk (RR) in two gender groups were 0.46 (0.33 - 0.64) and 0.39 (0.30 - 0.50) respectively. Multiple logistic regression analysis indicated that the history of hypertension, accumulative score of cerebral vascular hemodynamic indexes, age, gender and Nao'an Capsules intervention were the variables selected into the equation and significantly related to stroke. Among the variables, Nao'an Capsule was the strongest factor with a RR of 0.41.
Incidence of stroke in Nao'an Capsule intervention group was significantly lower than that in the general intervention group after 3 years of intervention, suggesting that Nao'an Capsule intervention was the strongest factor affecting stroke occurrence in individuals at high-risk.
评估使用脑安胶囊对高危人群预防中风的效果。
研究对象选自上海市南汇区696558名居民。年龄35岁及以上、至少有一项中风危险因素暴露的个体接受脑血管血液动力学检查。18271例脑血管血液动力学指标累计得分低于70分的病例被定义为高危个体并作为干预对象。根据参与者的意愿,10313例在一般干预措施基础上接受脑安胶囊强化干预,7958例仅接受一般干预。干预实施后,研究中风的发病率、死亡率及三年干预效果。
脑安胶囊组中风发病率显著低于一般干预组(P<0.01),男性为53.8%,女性为58.4%。两个性别组的相对风险(RR)分别为0.46(0.33 - 0.64)和0.39(0.30 - 0.50)。多因素logistic回归分析表明,高血压病史、脑血管血液动力学指标累计得分、年龄、性别及脑安胶囊干预是进入方程的变量,与中风显著相关。其中,脑安胶囊是最强因素,RR为0.41。
干预三年后脑安胶囊干预组中风发病率显著低于一般干预组,提示脑安胶囊干预是影响高危个体中风发生的最强因素。